Hello, Guest
Login
Sign Up
 
 

AMEX Stocks in Focus: PharmAthene, Hooper Holmes, IGI Laboratories, CEL-SCI Corporation

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 03/18/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

PharmAthene, Inc.(NYSEAMEX:PIP) went down 5.71% and closed at $1.65. Develops treatments of diseases associated with biological warfare threats. The Company operates as a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats.

How Should Investors Trade PIP After The Recent Movement? Find Out Here

Hooper Holmes, Inc.(NYSEAMEX:HH) added 1.15% and closed at $0.430. Hooper Holmes, Inc. (Hooper Holmes) is engaged in providing health risk assessment services to the life insurance and health industries Hooper Holmes operates in one business segment and provides paramedical and medical examinations, personal health interviews and record collection, and laboratory testing, which help life insurance companies evaluate the risks associated with underwriting policies.

Is HH Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

IGI Laboratories, Inc.(NYSEAMEX:IG) is higher 3.79% and closed at $1.37. IGI Laboratories, Inc. (IGI) develops, manufactures, fills and packs topical semi-solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers.

Is IG a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

CEL-SCI Corporation(NYSEAMEX:CVM) moved up 2.45% and closed at $0.259. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

How Should Investors Trade CVM After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.